Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Monterey Bio Acquisition Corporation MTRYW NASDAQ

NASDAQ Global Market • Financial Services • Shell Companies • US • USD

SharesGrow Score
23/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Monterey Bio Acquisition Corporation (MTRYW) is a Shell Companies company in the Financial Services sector, currently trading at $0.00. It has a SharesGrow Score of 21/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $1M (loss), growing at -14525009.6%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $20M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 0.23 (tight liquidity). Debt-to-assets is 0%. Total assets: $21M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

MTRYW SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MTRYW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
MTRYW: +0%/yr revenue is, -14525009.6%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet MTRYW: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 0.23 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
MTRYW: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range3.0E-4-0.055
Volume79.02K
Avg Volume (30D)16.51K
Market Cap$48.3M
Beta (1Y)0.00
Share Statistics
EPS (TTM)-0.44
Shares Outstanding$2.88M
IPO Date2021-11-22
CEOSanjeev Satyal
Financial Highlights & Ratios
Gross Profit$-2.04M
EBITDA$-2.04M
Net Income$-1.27M
Operating Income$-2.04M
Total Cash$145.81K
Net Debt$-145.81K
Total Assets$21.42M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD

Price Chart

Track all markets on TradingView
MTRYW
Monterey Bio Acquisition Corporation ↗  ·  NASDAQ Global Market
Financial Services • Shell Companies

People Also View

IXAQW
IXAQW
IX Acquisition Corp.
$0.07
+100.00%
 FEXDW
FEXDW
Fintech Ecosystem Development Corp.
$0.00
+6.25%
 FNVTW
FNVTW
Finnovate Acquisition Corp.
$0.02
+100.00%
 GATEW
GATEW
Marblegate Acquisition Corp.
$0.17
+5.56%
 PBAXW
PBAXW
Phoenix Biotech Acquisition Corp.
$0.06
-7.69%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$166.79
+1.15%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$312.93
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message